ADC Therapeutics SA logo

ADC Therapeutics SA

NYSE:ADCT

Overview | Financials
Company Name ADC Therapeutics SA
Symbol ADCT
Currency USD
Price 2.7
Market Cap 260,948,250
Dividend Yield 0%
52-week-range 0.36 - 6.04
Industry Biotechnology
Sector Healthcare
CEO Dr. Ameet Mallik M.B.A., M.S.
Website https://www.adctherapeutics.com

An error occurred while fetching data.

About ADC Therapeutics SA

ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; Phase III clinical

Related Stocks

Butterfly Network, Inc. logo

Butterfly Network, Inc.

BFLY

1.64 USD

Owlet, Inc. logo

Owlet, Inc.

OWLT

4.31 USD

Vicarious Surgical Inc. logo

Vicarious Surgical Inc.

RBOT

5.77 USD

ATI Physical Therapy, Inc. logo

ATI Physical Therapy, Inc.

ATIP

5.95 USD

Community Health Systems, Inc. logo

Community Health Systems, Inc.

CYH

5.7 USD

Financials

Numbers are in millions USD

Numbers are in millions USD